HRT RELATED ARTICLES |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2024
Pg. 6-14
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jan/Feb 2024
Pg. 16-21
|
Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
|
Jan/Feb 2024
Pg. 22-27
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 58
|
Estradiol 1-mg/0.1-g Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 59
|
Estriol and Estradiol 1.25, 2.5, and 5 mg (BiEst) Capsules
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 60
|
Progesterone 10% Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 61
|
Progesterone 100-mg/mL Sublingual Drops
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 62
|
Progesterone Vaginal Suppositories (Fatty Acid Base)
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 63
|
Testosterone 1 mg/0.1 mL in a PLO Gel
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 64
|
Triple Estrogen 2.5 mg Tablet Triturates
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 67
|
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
|
Sep/Oct 2023
Pg. 358-360
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Three Things You Need to Know Right Now
Brunner Scott
|
May/Jun 2022
Pg. 211-213
|
Everything Old is New Again
Brunner Scott
|
Jan/Feb 2022
Pg. 30-32
|
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
|
Jul/Aug 2021
Pg. 336-343
|
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
|
May/Jun 2021
Pg. 206-209
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
Stability of Fagron's Phytobase Cream Compounded with Various Hormones
Wynn Tom, Taylor Sarah, Zander Clark
|
Mar/Apr 2021
Pg. 156-162
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2
DeRosa Angela
|
Jan/Feb 2021
Pg. 14-17
|
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
|
Jan/Feb 2021
Pg. 24-28
|
PreScription: The NASEM cBHT Report, Part 1
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 444
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1
DeRosa Angela
|
Nov/Dec 2020
Pg. 466-470
|
Calculations
Stockton Shelly J
|
Mar/Apr 2020
Pg. 128
|
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 62
|
Calculations
Stockton Shelly J, Stover Emily M
|
Nov/Dec 2019
Pg. 484
|
Calculations
Stockton Shelly J, Drinnon Stephen D
|
Jul/Aug 2019
Pg. 312-313
|
Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches
Burrows Anna C, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L
|
Jul/Aug 2019
Pg. 340-350
|
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
|
Jan/Feb 2019
Pg. 62-64
|
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
|
Jan/Feb 2019
Pg. 77-81
|
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase)
Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
|
Nov/Dec 2018
Pg. 504-511
|
Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
|
May/Jun 2018
Pg. 190-195
|
Trace Level Analysis of Airborne Hormone Particulates
Trimble John O, Hampton Shanna
|
May/Jun 2018
Pg. 257-263
|
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 444
|
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O, Light Bob
|
Nov/Dec 2017
Pg. 530-535
|
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
|
May/Jun 2017
Pg. 238
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
|
Jan/Feb 2017
Pg. 6-16
|
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 39-45
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
|
Nov/Dec 2016
Pg. 447-454
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 407
|
Progesterone 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 412
|
Calculations
Stockton Shelly J
|
Jul/Aug 2016
Pg. 316-317
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce, Gogola Margaret
|
Jul/Aug 2015
Pg. 289-293
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jan/Feb 2015
Pg. 6-12
|
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014
Pg. 512-515
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Wiley TS, Odegard RD, Raden J, Haraldsen JT
|
Mar/Apr 2014
Pg. 162-168
|
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D, Daniels Kelly R
|
Jan/Feb 2014
Pg. 70-77
|
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina
|
Nov/Dec 2013
Pg. 452-457
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2013
Pg. 28-38
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Snyder Scott, Listecki Robert E
|
Sep/Oct 2012
Pg. 376-380
|
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris, Delano Amy
|
Mar/Apr 2012
Pg. 110-114
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
|
Jul/Aug 2011
Pg. 290-300
|
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Bramwell Bethany L
|
Nov/Dec 2010
Pg. 465-471
|
Bioidentical Hormones in the News
Bramwell Bethany L
|
Sep/Oct 2010
Pg. 374-380
|
The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
|
May/Jun 2010
Pg. 193-199
|
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject
Biundo Bruce
|
Mar/Apr 2010
Pg. 100-104
|
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
|
Mar/Apr 2010
Pg. 165-170
|
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing
Kells John, Dollbaum Charles M
|
Sep/Oct 2009
Pg. 392-399
|
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
|
Jul/Aug 2009
Pg. 314-317
|
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison
Chauhan Harsh, Atef Eman
|
Jul/Aug 2009
Pg. 342-344
|
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia
Spark M Joy, Dunn Rebecca A, Houlahan Kelli L
|
Jul/Aug 2009
Pg. 345-349
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jul/Aug 2009
Pg. 270-275
|
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation
Kells John, Dollbaum Charles M
|
Jul/Aug 2009
Pg. 280-288
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 450
|
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
|
Jul/Aug 2008
Pg. 375
|
Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
|
Jul/Aug 2008
Pg. 286-292
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A, Mead Jay H
|
Jul/Aug 2008
Pg. 310-315
|
Marketing for Your Community
Storey Patricia L
|
Jul/Aug 2008
Pg. 338-339
|
Calculations
Stockton Shelly J
|
Jul/Aug 2008
Pg. 354
|
Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008
Pg. 122-127
|
PreScription: Bias, NAMS, and HRT
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 266
|
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature
Paoletti Jim, Kaul Monica, Kloesel Lawson G
|
Jul/Aug 2007
Pg. 269-272
|
The History of Progesterone
Newton Stephen J
|
Jul/Aug 2007
Pg. 274-277
|
Premarin: The Intriguing History of a Controversial Drug
Vance Dwight A
|
Jul/Aug 2007
Pg. 282-286
|
Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement
Price Dared L
|
Jul/Aug 2007
Pg. 288-291
|
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones
Holt-Waldo NaRisa Y, Stephenson Kenna
|
Jul/Aug 2007
Pg. 292-296
|
The Politics of Hormone Replacement Therapy
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 278-281
|
Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
|
Jan/Feb 2007
Pg. 27
|
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006
Pg. 175-183
|
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update
Hu Fei-Shu, Reed-Kane Dana, Draugalis JoLaine R
|
May/Jun 2006
Pg. 187-192
|
Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women
Reed-Kane Dana, Grajeda Betty Jo
|
Jul/Aug 2005
Pg. 252
|
Book Reviews: Perfect Balance
Reed-Kane Dana, Grajeda Betty Jo
|
Jul/Aug 2005
Pg. 253-254
|
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Tan Robert S
|
Jul/Aug 2005
Pg. 259-264
View Sample |
Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy
White Irene Q
|
Jul/Aug 2005
Pg. 266
|
Natural Progesterone Handout
Kuntz Rachael
|
Jul/Aug 2005
Pg. 281-282
|
PostScription: Women in Balance: A Cause Worth Advancing
Murray Jane, Reilly Colleen
|
Jul/Aug 2005
Pg. 327-328
|
Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY
Reed-Kane Dana
|
Jan/Feb 2005
Pg. 5-6
|
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle
Reed-Kane Dana
|
Nov/Dec 2004
Pg. 412
|
Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate?
Tan Robert S
|
Nov/Dec 2004
Pg. 419-423
|
The Salivary Hormone Profile in the Clinical Evaluation of Women
Stephenson Kenna
|
Nov/Dec 2004
Pg. 427-435
|
Book and Literature Reviews
Reed-Kane Dana, Foy Elizabeth, MacCara Mary E, MacLean Lindsay
|
Sep/Oct 2004
Pg. 324-327
|
Book and Literature Reviews
Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
|
Jul/Aug 2004
Pg. 244-249
|
Estradiol 0.01% Wound Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 297
|
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy
Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
|
Jul/Aug 2004
Pg. 313-319
|
Andropause: New Perspectives
Biundo Bruce
|
May/Jun 2004
Pg. 175-178
|
Estrogen 0.625-mg/5-g Vaginal Gel
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 185
|
Testosterone Propionate 100-mg/mL in Oil Injection
Allen Loyd V Jr
|
May/Jun 2004
Pg. 222
|
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Cutter Christopher B
|
Mar/Apr 2004
Pg. 96-99
|
Women's Oral Health: Is There a Hormonal Link?
Preckshot John
|
Jan/Feb 2004
Pg. 10-14
|
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Cutter Christopher B
|
Jan/Feb 2004
Pg. 16-21
|
Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations
Branvold Andrea, Barner Jamie C
|
Nov/Dec 2003
Pg. 490-494
|
Book and Literature Reviews
Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
|
Sep/Oct 2003
Pg. 324-328
|
Patient Handout - Hormone Replacement Therapy
Reed-Kane Dana
|
Sep/Oct 2003
Pg. 339
|
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Gillson George R, Zava David T
|
Sep/Oct 2003
Pg. 330-338
|
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R, Zava David T
|
Jul/Aug 2003
Pg. 250-256
|
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
DiMaggio Jennifer Lyn, Reed-Kane Dana
|
Jul/Aug 2003
Pg. 258-263
|
Hydroxyprogesterone Caproate 250-mg/mL-in-Oil Injection
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 299
|
Sildenafil 25-mg Troches
Meece Jerry
|
May/Jun 2003
Pg. 171
|
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection
Meece Jerry
|
May/Jun 2003
Pg. 171
|
Panel Discussion: Prohormones
Ford Peter R, Pylant Phil, Roentsch George
|
Mar/Apr 2003
Pg. 94-99
|
Natural or Bioidentical Hormone Replacement: What makes the Difference? An Interview with Christopher B. Cutter, MD.
Vail Jane
|
Jan/Feb 2003
Pg. 24-26
|
Andropause: A Review of Treatment Options
Jonathan Bamarom H
|
Nov/Dec 2002
Pg. 458-461
|
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy
Santoro Filippo
|
Sep/Oct 2002
Pg. 378
|
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix
Timmons Evelyn D, Timmons Steven P
|
Sep/Oct 2002
Pg. 379
|
A Review of Current Research on the Effects of Progesterone
Boomsma Diane, Jim Paoletti
|
Jul/Aug 2002
Pg. 245-249
|
The Hormonal Link to Breast Cancer: The Estrogen Matrix
Zava David T
|
Jul/Aug 2002
Pg. 250-254
|
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Mason Dave
|
Jul/Aug 2002
Pg. 255-256
|
Establishing an Andropause Practice
Biundo Bruce
|
Jul/Aug 2002
Pg. 259-261
|
Dehydroepiandrosterone 25-mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 293
|
Dehydroepiandrosterone 25-mg/0.25-mL Sublingual Drops
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 294
|
Estradiol 0.5-mg Sublingual Troches
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 295
|
Estradiol 1-mg/0.1-mL Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 296
|
Estradiol 1-mg/0.1-g Topical Cream
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 297
|
Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 298
|
Estriol 2-mg/mL Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 299
|
Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 300
|
Testosterone 25-mg in Oil Capsules
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 301
|
Testosterone 50-mg/mL Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2002
Pg. 302
|
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Osburn Jennifer
|
May/Jun 2002
Pg. 171-176
|
Tranilast 0.8% for Iontophoresis
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 133
|
Tranilast Topical 2% Penetrating Mixture
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 134
|
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
|
Mar/Apr 2002
Pg. 142-146
|
Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Wepfer Scott T
|
Jan/Feb 2002
Pg. 50-54
|
Hormone Replacement Therapy, Part 2: Estrogen Defined
Lorentzen Jean
|
Nov/Dec 2001
Pg. 460-461
|
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
|
Nov/Dec 2001
Pg. 462-464
|
Flush Powder, No. 2
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
Tincture of Black Cohosh
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
Lydia Pinkham's Vegetable Compound
Worthen Dennis B
|
Sep/Oct 2001
Pg. 366
|
Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want
Reed-Kane Dana
|
Sep/Oct 2001
Pg. 332-335
View Sample |
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment
Lorentzen Jean
|
Sep/Oct 2001
Pg. 336-338
|
Bioidentical Hormones in the Treatment of Osteoporosis
Boomsma Diane
|
Sep/Oct 2001
Pg. 339-341
|
The Value of Hormone Assessment
Collins Joseph J
|
Sep/Oct 2001
Pg. 342-344
|
Estrogen Replacement: A Review of Current Literature
Parazewski Kevin
|
Sep/Oct 2001
Pg. 346-350
|
Treating Andropause: Prohormones and Hormone Metabolic Modifiers
Biundo Bruce
|
Sep/Oct 2001
Pg. 351-353
|
Bioidentical Topical Progesterone: A Survey of Patients
Warren Aileen, Listecki Robert E
|
Sep/Oct 2001
Pg. 354-355
|
Book Reviews: Hormone Replacement Therapy
Paoletti James E
|
Sep/Oct 2001
Pg. 356-357
|
Compounding in History: Treatment at the Change of Life
Worthen Dennis B
|
Sep/Oct 2001
Pg. 365-367
|
Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 374
|
Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 375
|
Libido Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 376
|
Progesterone 50-mg/mL Clear Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 377
|
Progesterone Low-Potency 0.0065% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 378
|
Sildenafil 1% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 379
|
Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO)
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 380
|
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 381
|
Testosterone 25-mg/mL Clear Solution
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 382
|
Testosterone 2% Scalp Lotion
Allen Loyd V Jr
|
Sep/Oct 2001
Pg. 383
|
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of
Girouard Lorinda G, Holm Richard C
|
May/Jun 2001
Pg. 218-220
|
Infertility Care and the Role of the Compounding Pharmacist
Filicpzuk Janina
|
Mar/Apr 2001
Pg. 136-139
|
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina, Garcia Lea
|
Jan/Feb 2001
Pg. 52-54
|
"Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach
Drisko Jeanne A
|
Nov/Dec 2000
Pg. 414-420
|
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina, Garcia Lea
|
Nov/Dec 2000
Pg. 421-422
|
Book Reviews: Women's Health
Reed-Kane Dana
|
Nov/Dec 2000
Pg. 424-425
|
Hormone Replacement Therapy: Selected Recent References
Foy Elizabeth, MacCara Mary E
|
Nov/Dec 2000
Pg. 426-427
|
Testosterone Deficiency in Men: New Treatments for Andropause
Biundo Bruce, Shippen Eugene
|
Nov/Dec 2000
Pg. 429-431
|
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists
Cutter Christopher B
|
Nov/Dec 2000
Pg. 432-437
View Sample |
Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 458
|
Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 459
|
Estrogen 0.625-mg/5-g Vaginal Gel
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 460
|
Progesterone Cycle Pack 35/50/75/100-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 461
|
Testosterone 1-mg/0.1-mL Nasal Spray
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 462
|
Testosterone 1-mg/0.1-mL in a PLO Gel
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 463
|
Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 464
|
Triple Estrogen 2.5-mg/0.1-mL PLO
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 465
|
Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 466
|
Triple Estrogen 2.5-mg Tablet Triturates
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 467
|
Estrogen Use in Dogs: Indications and Complications
Davidson Gigi S
|
Nov/Dec 2000
Pg. 468-470
|
Natural Estrogens: A Review of the Primary Literature
Glasnapp Andrew
|
Mar/Apr 2000
Pg. 110-114
|
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 461-465
|
Linguet Base (Soft Lozenge)
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 462
|
Sorbitol Based Hard Lozenges
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 462
|
Sucrose Based Hard Lozenges
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 462
|
Polyethylene Glycol (PEG) Troches (Soft Lozenges)
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 463
|
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges)
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 463
|
Chewable Lozenges
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 464
|
Interview: Katharina Dalton, MD: Progesterone and Related Topics
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 332-339
|
Top Ten HRT Compound Preparations
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 342
|
Wilson's Syndrome and T3 Therapy
Milner Martin
|
Sep/Oct 1999
Pg. 344-348
|
Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS
Ilyia Elias F, McLure Deborah, Farhat Michel Y
|
Sep/Oct 1999
Pg. 352-354
|
Andropause: Annotated Citations from the Literature
Biundo Bruce
|
Sep/Oct 1999
Pg. 355-356
|
Women's Health Book Reviews
Reed-Kane Dana
|
Sep/Oct 1999
Pg. 357-359
|
Planning and Marketing a Natural HRT Patient Seminar
Trent Kerry Cunningham
|
Sep/Oct 1999
Pg. 360-361
|
Lubricating Jelly Formula
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 388
|
Estriol 0.2-mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 392
|
Ethinyl Estradiol 0.2-mg Gelatin Troches
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 393
|
Progesterone 50-mg/mL Topical Gel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 394
|
Progesterone 100-mg/mL Sublingual Drops
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 395
|
Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 396
|
Progesterone 10% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 397
|
Progesterone 200-mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 398
|
Testosterone 1-mg Buccal Troches
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 399
|
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 400
|
Triple Estrogen 2.5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 401
|
Estradiol 5-mg/mL-in-Oil Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 300
|
Tri-Est 2.5-mg/mL Aqueous Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 304
|
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography
Gupta Vishnu D, Pramar Y
|
Jul/Aug 1999
Pg. 314-315
|
Progesterone 100-mg/mL Veterinary Injection
Allen Loyd V Jr
|
May/Jun 1999
Pg. 223
|
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography
Gupta Vishnu D
|
May/Jun 1999
Pg. 239-240
|
Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis
Milner Martin
|
Mar/Apr 1999
Pg. 76-79
|
Male Impotency and the Compounding Pharmacist
Preckshot John
|
Mar/Apr 1999
Pg. 80-83
|
Medication Combinations for Penile Injections
Preckshot John
|
Mar/Apr 1999
Pg. 81
|
Natural Testosterone: Hormone of the Heart
Wright Jonathan V, Lenard Lane
|
Mar/Apr 1999
Pg. 88-98
|
Case Report: Testosterone Supplementation in a Vasectomy Patient
Jagodzinski Pat
|
Mar/Apr 1999
Pg. 101
|
Natural HRT: Corrective Measures When the System Goes Down
Ford Gina
|
Mar/Apr 1999
Pg. 109
|
Dehydroepiandrosterone 50-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 131
|
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 134
|
Sildenafil Citrate 25-mg Sublingual Troches
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 135
|
Testosterone-Menthol Eutectic Ointment (2% Testosterone)
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 137
|
Testosterone 10-mg Troches
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 138
|
Testosterone 10-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 139
|
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags
White C Michael, Quercia Robert
|
Mar/Apr 1999
Pg. 156-157
|
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography
Gupta Vishnu D
|
Mar/Apr 1999
Pg. 158-159
|
In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1
Foldvari Marianna, Oguejifor Cosmas
|
Mar/Apr 1999
Pg. 160-163
|
HRT Marketing Tip
|
Jan/Feb 1999
Pg. 37
|
Progesterone 200-mg/mL in Grapeseed-Oil Suspension
Allen Loyd V Jr
|
Nov/Dec 1998
Pg. 442
|
Triple Estrogen 2.5-mg Capsules (Lactose Free)
Allen Loyd V Jr
|
Nov/Dec 1998
Pg. 445
|
Treatment of Skin Aging with Topical Estrogens
Schmidt Jolanta B, Binder Martina, Demschik Gabriele, Bieglmayer Christian, Reiner Angelika
|
Jul/Aug 1998
Pg. 270-275
|
Essential Truths About HRT
Everett Lisa, Everett Eric
|
Jan/Feb 1998
Pg. 10-11
|
Interview on HRT: Christiane Northrup, MD, FACOG
Allen Loyd V Jr, Northrup Christiane
|
Jan/Feb 1998
Pg. 12-17
|
HRT and the Continuing Education of Health Care Professionals
Boomsma Diane
|
Jan/Feb 1998
Pg. 18-19
|
Estrogen and Breast Cancer: Is There a Link?
Gever Marcy Portnoff
|
Jan/Feb 1998
Pg. 21-23
|
Estrogen in the Treatment and Prevention of Alzheimer's Disease
Paganini-Hill Annlia, Henderson Victor W
|
Jan/Feb 1998
Pg. 24-29
|
Reviews: Books on HRT
Ford Gina
|
Jan/Feb 1998
Pg. 30-34
|
Estradiol 1-mg Vaginal Suppositories
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 48
|
Estradiol Topical Gel
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 49
|
Estradiol Vaginal Cream (0.2%)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 50
|
Estradiol Vaginal Gel (0.2%)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 51
|
Methyltestosterone 6-mg/g Gel
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 52
|
Progesterone Enema 100- and 200-mg/mL
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 53
|
Progesterone-Estradiol-Testosterone in Oil Capsules
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 54
|
Progesterone in Oil Capsules
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 55
|
Progesterone Nasal Spray (2%)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 56
|
Progesterone Oral Suspension (40-mg/mL)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 57
|
Progesterone 3% Vaginal Gel
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 58
|
Progesterone Troches (100-mg, Soft)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 59
|
Progesterone Troches (300-mg, Hard)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 60
|
Progesterone Troches (400-mg, Soft)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 61
|
Progesterone 200-mg Buccal Tablets
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 62
|
Progesterone 200-mg Linguets (Soft)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 63
|
Progesterone Vaginal Cream (5%)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 64
|
Progesterone Vaginal Suppositories (Fatty Acid Base)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 65
|
Progesterone Vaginal Suppositories (Polyethylene Glycol Bases)
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 66
|
Testosterone Propionate Gel
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 67
|
Testosterone Propionate 100-mg/6 mL Cream
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 68
|
Testosterone Propionate 2% Ointment
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 69
|
Testosterone 0.625-mg Troches
Allen Loyd V Jr
|
Jan/Feb 1998
Pg. 70
|
Estriol Solution for Iontophoresis for Acne Scars
Allen Loyd V Jr
|
Nov/Dec 1997
Pg. 411
|
Assaying Progesterone in Extemporaneously Prepared Suppositories
Al-Achi Antoine, Webster Kathy, Greenwood Robert, Nicol Scott
|
Sep/Oct 1997
Pg. 339
|
The Changing Body
Allen Loyd V Jr
|
May/Jun 1997
Pg. 144-146
|
Progesterone 100-mg in Peanut-Oil Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 182
|
Triple Estrogen 2.5-mg in Oil Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 185
|
Triple Estrogen 2.5-mg in Lactose Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 186
|
Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 187
|
HDDM Hard Troche
Allen Loyd V Jr
|
Jan/Feb 1997
Pg. 29
|
HDDM Soft Troche
Allen Loyd V Jr
|
Jan/Feb 1997
Pg. 30
|
HDDM Sugar Troche
Allen Loyd V Jr
|
Jan/Feb 1997
Pg. 30
|
Return to Top |